会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • Methods and apparatus for the CVCS
    • CVCS的方法和装置
    • US20110301569A1
    • 2011-12-08
    • US13199012
    • 2011-08-16
    • Gordon Wayne Dyer
    • Gordon Wayne Dyer
    • A61F11/00A61M37/00
    • A61K9/0043A61K9/0073A61M15/0098A61M16/0866A61M2202/0468A61M2210/0675
    • The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (CVCS) via a Valsalva manuever. Because the CVCS is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply. Instead, because in its closed-system blood can flow in any direction, the blood of the CVCS and any medicaments that it contains will be drawn to any portion of it where there is increased outflow, such as the copious venous-derived sinus fluid drainage present during nasal allergy or nasal infection. Thus, the very nasal congestion that impedes the effectiveness of direct medicament application, such as seen with nasal inhalers or systemic antibiotics, aids in applying the medicament indirectly to the nasal sinuses via the CVCS. Additionally, the present method has the benefit of delivering medicaments that, unlike present treatment regimens, are not limited solely to those medicaments that can be successfully absorbed from the G.I. tract. This means that, in the case of antibiotics, the bacteria infecting this portion of the CVCS will not be as resistant to treatment if they have not had prior exposure to this new line of antibiotics. Finally, if the infection extends to the eardrums, making the Valsalva maneuver painful, or if the patient is simply unusually sensitive, then earplugs to reduce the stress on the eardrums may be worn while the patient performs the Valsalva maneuver.
    • 本发明提供了一种通过首先通过Valsalva manuever将药物加载到脑脊静脉系统(CVCS)中来向鼻窦供应高浓度药物,特别是抗生素的间接方法和伴随装置。 因为CVCS是一种无阀式三维封闭系统,传统的生理教条如静脉总是排出组织并不总是适用。 相反,因为在其闭合系统的血液中可以流向任何方向,CVCS的血液及其含有的任何药物将被吸入其中流出物增加的任何部分,例如大量静脉导出的窦液引流 鼻过敏或鼻感染时出现。 因此,妨碍直接药物应用的有效性的鼻部充血,例如用鼻吸入器或全身抗生素观察,有助于通过CVCS间接地将药物施用于鼻窦。 此外,本方法具有递送药物的益处,其与现有的治疗方案不同,不仅仅限于可以从G.I.成功吸收的那些药物。 道。 这意味着,在抗生素的情况下,感染CVCS的这一部分的细菌如果没有接触过这种新的抗生素系列,就不会像治疗一样耐药。 最后,如果感染延伸到耳膜,使Valsalva手术变得痛苦,或者如果患者仅仅是异常敏感的话,那么当患者进行Valsalva手术时,可能会佩戴耳塞以减轻耳膜上的压力。